digital therapeutics

AI, DTx at the Forefront in 2020 & More News

Digital Health Experts Needed for International Forum

The IDIH Project (International Digital Health Cooperation for Preventive, Integrated, Independent and Inclusive Living) is seeking digital health experts who are interested in collaborating on a sustainable platform for international cooperation in digital health. IDIH is a project funded under the European Union Horizon 2020 Research and Innovation Programme, bringing together prominent organizations from EU and five Strategic Partner Countries (Canada, China, Japan, South Korea and the USA) to promote and increase international collaboration, advance digital health, and support active and healthy aging through innovation. 

IDIH is looking for individuals whose expertise is in alignment with the following focus areas: preventative care, integrated care, independent and connected living, and inclusive living. 

If you would like to be a part of our expert driven Digital Health Transformation Forum, please send your CV with a short explanation on why you are interested in becoming an Expert Group member or Chair to experts@idih-global.eu by January 31st, 2020. 

Act fast—experts are chosen on a rolling basis!

Digital Therapeutics Expected to Advance Despite Recent Losses 

Despite the recent string of failed collaborations between digital therapeutics (DTx) and pharmaceutical companies, the DTx sector is predicted to grow in the coming year. Richard Close, an analyst at Canaccord Genuity, suggests that key players in the health care arena are attuned to the benefits of DTx solutions for treating patients. One such player is Express Scripts, the largest independent manager of pharmacy benefits in the U.S., whose formulary highlights vetted DTx offerings from companies like Livongo, WellDoc, SilverCloud Health, and Learn to Live. Though consumers are still waiting for clinical validation of DTx through the pharma partnerships, both DTx developers and key care management stakeholders remain optimistic about the value of DTx for clinical uses. 

“Re-Humanization” of Medicine through AI

A report from the social-listening platform Digimind reveals that adoption of artificial intelligence (AI) and machine learning (ML) will continue to be a priority for health care and technology sectors in 2020. The boom of value-based care and patient centric models of operation showcase a desire to “re-humanize” medicine—allowing practitioners to spend more time with the patient and less with paperwork. In recent years, the development of AI and ML has been focused on their ability to make accurate interpretations of diagnostic screenings and to extract key data from patient records. The digital health space can expect to see further development of AI’s medical sensitivity and accuracy to maximize output at the lowest cost.